The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
|
---|---|
Published in |
Cancer (0008543X), February 2014
|
DOI | 10.1002/cncr.28592 |
Pubmed ID | |
Authors |
Rajesh V. Lalla, Joanne Bowen, Andrei Barasch, Linda Elting, Joel Epstein, Dorothy M. Keefe, Deborah B. McGuire, Cesar Migliorati, Ourania Nicolatou‐Galitis, Douglas E. Peterson, Judith E. Raber‐Durlacher, Stephen T. Sonis, Sharon Elad, The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology . |
Abstract |
Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for mucositis. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Argentina | 1 | 20% |
Unknown | 4 | 80% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Practitioners (doctors, other healthcare professionals) | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 987 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Turkey | 1 | <1% |
Italy | 1 | <1% |
Ecuador | 1 | <1% |
Jamaica | 1 | <1% |
Korea, Republic of | 1 | <1% |
Spain | 1 | <1% |
Greece | 1 | <1% |
Unknown | 980 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 146 | 15% |
Student > Bachelor | 103 | 10% |
Other | 78 | 8% |
Student > Postgraduate | 73 | 7% |
Researcher | 68 | 7% |
Other | 242 | 25% |
Unknown | 277 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 397 | 40% |
Nursing and Health Professions | 91 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 55 | 6% |
Agricultural and Biological Sciences | 33 | 3% |
Biochemistry, Genetics and Molecular Biology | 30 | 3% |
Other | 60 | 6% |
Unknown | 321 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2023.
All research outputs
#1,139,300
of 26,559,762 outputs
Outputs from Cancer (0008543X)
#917
of 14,412 outputs
Outputs of similar age
#10,585
of 235,730 outputs
Outputs of similar age from Cancer (0008543X)
#21
of 117 outputs
Altmetric has tracked 26,559,762 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 14,412 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.8. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 235,730 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 117 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.